U.S. markets closed

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Precio retrasado. Divisa en EUR.
Añadir a la lista de seguimiento
28.32-0.35 (-1.22%)
Al cierre: 05:35PM CEST

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Sector(es)Healthcare
IndustriaDrug Manufacturers - General
Empleados a tiempo completo98,189

Ejecutivos clave

NombreTítuloPagarEjecutadoAño de nacimiento
Mr. William N. AndersonChairman of the Management Board & CEO8.43MN/D1966
Mr. Wolfgang U. NicklCFO & Member of Management Board1.98MN/D1969
Mr. Stefan OelrichHead of the Pharmaceuticals Division & Member of the Board of Management1.95MN/D1968
Mr. Rodrigo SantosMember of Management Board & President of the Crop Science Division2.17MN/D1973
Ms. Heike PrinzChief Talent Officer, Labor Director & Member of Management Board1.33MN/D1964
Mr. Julio TrianaMember of Management Board & President of Consumer Health DivisionN/DN/D1966
Dr. Sebastian Guth Ph.D.Chief Operating OfficerN/DN/DN/D
Dr. Jost ReinhardHead of Investor RelationsN/DN/D1972
Mr. Michael PreussHead of Communications, Government Relations and Corporate BrandN/DN/DN/D
Mr. Bernd-Peter BierHead of Group FinanceN/DN/D1967
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Pago corresponde al salario, las bonificaciones, etc. Ejecutado corresponde al valor de las opciones ejecutadas durante el año fiscal. Divisa en EUR.

Descripción

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Gestión corporativa

La calificación ISS Governance QuickScore de Bayer Aktiengesellschaft a partir del 1 de mayo de 2024 es 3. Las puntuaciones principales son Auditoría: 10; Junta: 2; Derechos del accionista: 1; Compensación: 2.

Las puntuaciones de la gestión corporativa son cortesía de Servicios de accionistas institucionales (ISS). Las puntuaciones indican una posición decil en relación con el índice o la región. Una puntuación decil 1 indica que el riesgo de gestión es menor, mientras que una puntuación decil 10 indica que el riesgo de gestión es mayor.